CLINICAL_TRIALS
trial_result
· 2025-04-24
Clinical Trial Update: Phase 2b Study of MBS2320 in Participants With Methotrexate-Refractory RA [Phase 2]
Summary
Phase 2b study of MBS2320 in methotrexate-refractory rheumatoid arthritis has completed, with results posted in April 2025.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Modern Biosciences Ltd | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2025-04-24